Compare BTMD & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | CPIX |
|---|---|---|
| Founded | 2012 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.0M | 73.6M |
| IPO Year | 2021 | 2007 |
| Metric | BTMD | CPIX |
|---|---|---|
| Price | $2.20 | $6.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.83 | N/A |
| AVG Volume (30 Days) | ★ 404.5K | 42.7K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 722.22 | 58.70 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $192,219,000.00 | $42,010,949.00 |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $33.17 | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $1.27 | $1.85 |
| 52 Week High | $4.75 | $7.21 |
| Indicator | BTMD | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 53.69 | 57.66 |
| Support Level | $1.97 | $5.42 |
| Resistance Level | $2.44 | $6.61 |
| Average True Range (ATR) | 0.19 | 0.43 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 64.37 | 51.82 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.